Drug Shortage Report for MYLAN-BUPROPION XL

Last updated on 2019-06-19 History
Report ID 3944
Drug Identification Number 02382083
Brand name MYLAN-BUPROPION XL
Common or Proper name BUPROPION XL
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) BUPROPION HYDROCHLORIDE
Strength(s) 300MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 90BT, 500BT
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-05-24
Actual start date 2018-05-25
Estimated end date 2019-09-30
Actual end date 2019-06-18
Shortage status Resolved
Updated date 2019-06-19
Company comments Manufacturing issues
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-03-22 English Compare
v2 2017-03-22 English Compare
v3 2017-03-22 French Compare
v4 2017-04-19 English Compare
v5 2017-04-19 French Compare
v6 2017-05-16 English Compare
v7 2017-05-16 French Compare
v8 2017-05-26 English Compare
v9 2017-05-26 French Compare
v10 2017-06-22 English Compare
v11 2017-06-22 French Compare
v12 2017-06-22 English Compare
v13 2017-06-22 French Compare
v14 2017-08-17 English Compare
v15 2017-08-17 French Compare
v16 2017-09-22 English Compare
v17 2017-09-22 English Compare
v18 2017-09-22 French Compare
v19 2017-09-22 English Compare
v20 2017-09-22 French Compare

Showing 1 to 20 of 95